Sign In
Buy CLB
$11.77
+0.0800 (+0.684%)
At Close: Jun 22, 2026
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock?
10:36am, Thursday, 15'th May 2025
CLB struggles with a 4.4% revenue decline, low ROIC in the first quarter of 2025, minimal dividends and vulnerability to oil price volatility and geopolitical instability.
New Strong Sell Stocks for May 14th
07:35am, Wednesday, 14'th May 2025
AMTB, CLB and EXPI have been added to the Zacks Rank #5 (Strong Sell) List on May 14, 2025.
Core Laboratories Q1 Earnings Miss Estimates, Expenses Increase YoY
08:00am, Friday, 25'th Apr 2025
CLB's first-quarter earnings miss estimates due to the underperformance of the Reservoir Description segment.
Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript
02:14pm, Thursday, 24'th Apr 2025
Core Laboratories Inc. (NYSE:CLB ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice Preside
New Strong Sell Stocks for April 24th
07:25am, Thursday, 24'th Apr 2025
AMPY, CARS and CLB have been added to the Zacks Rank #5 (Strong Sell) List on April 24, 2025.
Core Laboratories (CLB) Q1 Earnings and Revenues Lag Estimates
07:10pm, Wednesday, 23'rd Apr 2025
Core Laboratories (CLB) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago.
CORE LAB REPORTS FIRST QUARTER 2025 RESULTS
05:15pm, Wednesday, 23'rd Apr 2025
REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAR OPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEM
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
06:40am, Monday, 21'st Apr 2025
CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
11:07am, Wednesday, 16'th Apr 2025
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How to Play Core Labs Stock Ahead of Its Q1 Earnings Release
07:20am, Monday, 14'th Apr 2025
CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution.
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
04:15pm, Monday, 24'th Mar 2025
HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025.
Is Core Stock Worth Buying After a 27% Surge in 6 Months?
07:20am, Monday, 03'rd Mar 2025
CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions.
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report?
12:36pm, Friday, 28'th Feb 2025
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase
07:57am, Friday, 31'st Jan 2025
Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.
Core Laboratories Inc. (CLB) Q4 2024 Earnings Conference Call Transcript
10:05pm, Thursday, 30'th Jan 2025
Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice Presi
